NASDAQ:CTKB Cytek Biosciences (CTKB) Earnings Date, Estimates & Call Transcripts $8.07 -0.12 (-1.47%) (As of 06/2/2023 06:55 PM ET) Add Compare Share Share Today's Range$7.98▼$8.3650-Day Range$6.69▼$11.9952-Week Range$6.45▼$16.05Volume605,500 shsAverage Volume1.10 million shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/APrice Target$14.33 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Earnings Summary Upcoming Earnings DateAug. 9EstimatedActual EPS (Feb. 28) $0.03 Beat By $0.01 Consensus EPS (Feb. 28) $0.02 Last Year's Q1 EPS (2/23/2022) $0.05Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCTKB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CTKB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Cytek Biosciences Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20231$0.01$0.01$0.01 Q2 20231$0.01$0.01$0.01 Q3 20231$0.02$0.02$0.02 Q4 20231$0.02$0.02$0.02 FY 20234$0.06$0.06 $0.06 Get Cytek Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for CTKB and its competitors with MarketBeat's FREE daily newsletter. CTKB Earnings Date and InformationCytek Biosciences last posted its earnings data on February 28th, 2023. The reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The company had revenue of $48.34 million for the quarter, compared to analyst estimates of $49.87 million. Cytek Biosciences has generated ($0.01) earnings per share over the last year (($0.01) diluted earnings per share). Earnings for Cytek Biosciences are expected to grow by 128.57% in the coming year, from $0.07 to $0.16 per share. Cytek Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off prior year's report dates.Read More Cytek Biosciences Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/9/2023(Estimated) 2/28/2023Q4 2022$0.02$0.03+$0.01$0.03$49.87 million$48.34 million11/9/2022Q3 2022$0.02$0.01($0.01)$0.01$43.36 million$40.48 million8/10/2022Q2$0.02$0.03+$0.01$41.34 million$40.16 million 5/11/2022Q1 2022$0.01($0.02)($0.03)($0.02)$33.00 million$35.06 million 2/23/2022Q4 2021$0.05+$0.05$0.10$38.89 million11/8/20219/30/2021$0.02$0.02$34.38 million Cytek Biosciences Earnings - Frequently Asked Questions When is Cytek Biosciences's earnings date? Cytek Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates. Learn more on CTKB's earnings history. Did Cytek Biosciences beat their earnings estimates last quarter? In the previous quarter, Cytek Biosciences (NASDAQ:CTKB) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.01. Learn more on analysts' earnings estimate vs. CTKB's actual earnings. How much revenue does Cytek Biosciences generate each year? Cytek Biosciences (NASDAQ:CTKB) has a recorded annual revenue of $164.04 million. How much profit does Cytek Biosciences generate each year? Cytek Biosciences (NASDAQ:CTKB) has a recorded net income of $2.58 million. CTKB has generated -$0.01 earnings per share over the last four quarters. What is Cytek Biosciences's EPS forecast for next year? Cytek Biosciences's earnings are expected to grow from $0.07 per share to $0.16 per share in the next year, which is a 128.57% increase. More Earnings Resources from MarketBeat Related Companies: Quanterix Earnings Date Nautilus Biotechnology Earnings Date Olink Holding AB (publ) Earnings Date Pacific Biosciences of California Earnings Date Alignment Healthcare Earnings Date OPKO Health Earnings Date ImmunityBio Earnings Date Replimune Group Earnings Date Beauty Health Earnings Date Summit Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Trading Channel Breakout in Lululemon Brought by EarningsNordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard? This page (NASDAQ:CTKB) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.